Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jun-Beom Lee, Ho Geol Woo, Yoonkyung Chang, Yoon Mi Jin, Inho Jo, Jinkwon Kim & Tae-Jin Song. (2019) Plasma Klotho concentrations predict functional outcome at three months after acute ischemic stroke patients. Annals of Medicine 51:3-4, pages 262-269.
Read now
Read now
David Bonifačić, Merica Aralica, Vlatka Sotošek Tokmadžić, Valentino Rački, Lidija Tuškan-Mohar & Natalia Kučić. (2017) Values of vanillylmandelic acid and homovanillic acid in the urine as potential prognostic biomarkers in ischaemic stroke patients. Biomarkers 22:8, pages 790-797.
Read now
Read now
Mette Bjerre, Jørgen Hilden, Jens Kastrup, Maria Skoog, Jørgen F. Hansen, Hans J. Kolmos, Gorm B. Jensen, Erik Kjøller, Per Winkel, Allan Flyvbjerg & Christian Gluud. (2014) Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: The CLARICOR trial. Scandinavian Journal of Clinical and Laboratory Investigation 74:8, pages 657-664.
Read now
Read now
Articles from other publishers (23)
Songül Hatiboglu, Fatih Yanar, Alper Ozturk, Yılmaz Basar, Mehmet Aydogan, Elif Ozkok, Seref Demirel & Nihal Salmayenli. (2023) Peroxisome proliferator-activated receptor gamma and osteoprotegerin levels as an indicator and diagnostic predictor of endothelial dysfunction. Turkish Journal of Biochemistry 0:0.
Crossref
Crossref
Hyung Jun Kim, Moo-Seok Park, Ahran Joo, Seungji Kang, Seuhyun Eum, Yoonkyung Chang & Tae-Jin Song. (2022) Plasma osteoprotegerin level is associated with hemorrhagic transformation in stroke patients who underwent endovascular thrombectomy. Clinical Neurology and Neurosurgery 219, pages 107305.
Crossref
Crossref
Sauson Soldozy, Kaan Yağmurlu, Pedro Norat, Mazin Elsarrag, John Costello, Faraz Farzad, Jennifer D. Sokolowski, Khadijeh A. Sharifi, Turki Elarjani, Joshua Burks, Petr Tvrdik, Mark E. Shaffrey, Min S. Park, Robert M. Starke, Errol Gordon & M. Yashar S. Kalani. (2022) Biomarkers Predictive of Long-Term Outcome After Ischemic Stroke: A Meta-Analysis. World Neurosurgery 163, pages e1-e42.
Crossref
Crossref
Moo-Seok Park, Jin-Hee Park, Ahran Joo, Yoonkyung Chang & Tae-Jin Song. (2022) The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study. PeerJ 10, pages e13327.
Crossref
Crossref
Ryerson Fonseca Mota, Paulo Henrique Cavalcanti de Araújo, Maria Eduarda Ramos Cezine, Flávia Sayuri Matsuo, Rodrigo Jair Morandi Metzner, Carlos Alberto Oliveira de Biagi Junior, Kamila Chagas Peronni, Hiroki Hayashi, Munehisa Shimamura, Hironori Nakagami & Mariana Kiomy Osako. (2022) RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages. BioMed Research International 2022, pages 1-13.
Crossref
Crossref
Moo-Seok Park, Yoonkyung Chang, Kwang-Hyun Kim, Jin Hee Park & Tae-Jin Song. (2021) Plasma osteoprotegerin levels are associated with the presence and burden of cerebral small vessel disease in patients with acute ischemic stroke. Clinical Neurology and Neurosurgery 210, pages 107010.
Crossref
Crossref
Reiko Hanada. (2020) The role of the RANKL/RANK/OPG system in the central nervous systems (CNS). Journal of Bone and Mineral Metabolism 39:1, pages 64-70.
Crossref
Crossref
Yoonkyung Chang, Jinkwon Kim, Ho Geol Woo, Dong-Ryeol Ryu, Hyung Jung Oh & Tae-Jin Song. (2020) Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients. Journal of Clinical Neurology 16:1, pages 29.
Crossref
Crossref
Ho Geol Woo, Yoonkyung Chang, Dong-Ryeol Ryu & Tae-Jin Song. (2019) Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke. PLOS ONE 14:8, pages e0220796.
Crossref
Crossref
Yanyan Cao, Congxian Cui, Hongqin Zhao, Xudong Pan, Wenjian Li, Kun Wang & Aijun Ma. (2019) Plasma Osteoprotegerin Correlates with Stroke Severity and the Occurrence of Microembolic Signals in Patients with Acute Ischemic Stroke. Disease Markers 2019, pages 1-7.
Crossref
Crossref
Jarosław Wajda, Maciej Świat, Aleksander J. Owczarek, Michał Holecki, Jan Duława, Aniceta Brzozowska, Magdalena Olszanecka-Glinianowicz & Jerzy Chudek. (2019) Osteoprotegerin Assessment Improves Prediction of Mortality in Stroke Patients. Journal of Stroke and Cerebrovascular Diseases 28:5, pages 1160-1167.
Crossref
Crossref
K. Mathold, P. Wanby, L. Brudin, S. P. Von & M. Carlsson. (2018) Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke. PLOS ONE 13:11, pages e0207348.
Crossref
Crossref
Krzysztof Szewczak, Magdalena Niespialowska, Beata Jakubowska-Solarska, Magdalena Chalabis & Jacek Gawlowicz. (2017) Prospective of ischemic stroke biomarkers. Current Issues in Pharmacy and Medical Sciences 30:2, pages 69-74.
Crossref
Crossref
Hongqin Zhao, Yanyan Cao, Honghua Chen, Wanqun Xu, Ximei Sun & Xudong Pan. (2017) The association between OPG rs3102735 gene polymorphism, microembolic signal and stroke severity in acute ischemic stroke patients. Gene 613, pages 25-29.
Crossref
Crossref
A F Verbovoy, I A Tsanava, E V Mitroshina & L A Sharonova. (2017) Osteoprotegerin is a new marker of cardiovascular diseases. Terapevticheskii arkhiv 89:4, pages 91-94.
Crossref
Crossref
Jolanta M. Siller-Matula, Irene M. Lang, Christian Schoergenhofer, Mark Roest & Bernd Jilma. (2017) Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention. Thrombosis and Haemostasis 117:09, pages 1730-1738.
Crossref
Crossref
Cristina Vassalle & Annamaria Mazzone. (2016) Bone loss and vascular calcification: A bi-directional interplay?. Vascular Pharmacology 86, pages 77-86.
Crossref
Crossref
De-Hua SongPeng-Zhen ZhouXiao-Lin XiuGuang-Hui ZhouYu-Xia SunChun Song. (2016) Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. Medical Science Monitor 22, pages 1223-1231.
Crossref
Crossref
Federico Carbone, Nicolas Vuilleumier, Fabienne Burger, Gloria Roversi, Carmine Tamborino, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Marina Padroni, Franco Dallegri, François Mach, Enrico Fainardi & Fabrizio Montecucco. (2015) Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke. European Journal of Clinical Investigation 45:6, pages 579-586.
Crossref
Crossref
Cristina Vassalle, Silvia Maffei & Giorgio Iervasi. 2015. Biomarker Validation. Biomarker Validation
107
146
.
Munehisa ShimamuraHironori NakagamiMariana K. OsakoHitomi KurinamiHiroshi KoriyamaPang ZhengdaHideki Tomioka, Akiko TenmaKouji Wakayama & Ryuichi Morishita. (2014) OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proceedings of the National Academy of Sciences 111:22, pages 8191-8196.
Crossref
Crossref
Tae-Jin Song, Jinkwon Kim, Hye Sun Lee, Chung Mo Nam, Hyo Seok Nam, Eun Hye Kim, Ki Jeong Lee, Dongbeom Song, Ji Hoe Heo & Young Dae Kim. (2017) Differential impact of unrecognised brain infarction on stroke outcome in non-valvular atrial fibrillation. Thrombosis and Haemostasis 112:12, pages 1312-1318.
Crossref
Crossref
Changlei Guo, Fudong Hu, Shaoli Zhang, Yakun Wang & Hengdao Liu. (2013) Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients. Genetics and Molecular Biology 36:2, pages 177-182.
Crossref
Crossref